Top rated lung cancer clinical trials in Baltimore, Maryland
Here are the top 10 medical studies for lung cancer in Baltimore, Maryland
Popular filter options for lung-cancer baltimore trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Procedure
Surgery or High-Dose Radiation for Metastatic Breast Cancer
Recruiting1 awardPhase 2 & 3
West Reading, Pennsylvania
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Tyrosine Kinase Inhibitor
Crizotinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.
Proton Beam Therapy
Photon vs Proton Radiation for Non-Small Cell Lung Cancer
Recruiting3 awardsPhase 3
Baltimore, Maryland
This trial is comparing two types of radiation therapy to see which is more effective in treating patients with stage II-IIIB non-small cell lung cancer- proton chemoradiotherapy versus photon chemoradiotherapy.
Checkpoint Inhibitor
Immunotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Philadelphia, Pennsylvania
This trial is testing whether Nivolumab, or a combination of Nivolumab and Ipilimumab, or Nivolumab and Platinum-Doublet Chemotherapy can help people with advanced lung cancer live longer without their disease getting worse, or improve overall survival.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Procedure
Surgery or High-Dose Radiation for Metastatic Breast Cancer
Recruiting1 awardPhase 2 & 3
West Reading, Pennsylvania
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Tyrosine Kinase Inhibitor
Crizotinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.
View More Lung-cancer Baltimore Trials
See another 83 medical studies focused on lung-cancer baltimore.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.